NSN Co. Ltd (031860) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.143x

Based on the latest financial reports, NSN Co. Ltd (031860) has a cash flow conversion efficiency ratio of -0.143x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.89 Billion ≈ $-1.96 Million USD) by net assets (₩20.26 Billion ≈ $13.73 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See NSN Co. Ltd (031860) defensive interval to measure how many days the company can operate on defensive assets alone.

NSN Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how NSN Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

NSN Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NSN Co. Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Harta Djaya Karya Tbk Pt
JK:MEJA
0.291x
Embelton Ltd
AU:EMB
0.033x
Kingfish Company Nv
OL:KING
-0.078x
Park Ha Biological Technology Co., Ltd.
NASDAQ:BYAH
N/A
Sahathai Terminal Public Company Limited
BK:PORT
0.050x
FASING SA
WAR:FSG
0.009x
Nukkleus Inc
NASDAQ:NUKK
0.033x
Femasys Inc
NASDAQ:FEMY
-0.568x

Annual Cash Flow Conversion Efficiency for NSN Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of NSN Co. Ltd from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see NSN Co. Ltd market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 ₩20.26 Billion
≈ $13.73 Million
₩-8.86 Billion
≈ $-6.01 Million
-0.437x -274.65%
2024-12-31 ₩48.12 Billion
≈ $32.61 Million
₩-5.62 Billion
≈ $-3.81 Million
-0.117x +12.82%
2023-12-31 ₩59.75 Billion
≈ $40.49 Million
₩-8.00 Billion
≈ $-5.42 Million
-0.134x +29.67%
2022-12-31 ₩59.58 Billion
≈ $40.38 Million
₩-11.35 Billion
≈ $-7.69 Million
-0.190x +40.54%
2021-12-31 ₩38.49 Billion
≈ $26.08 Million
₩-12.33 Billion
≈ $-8.35 Million
-0.320x -266.26%
2020-12-31 ₩51.00 Billion
≈ $34.56 Million
₩-4.46 Billion
≈ $-3.02 Million
-0.087x +54.68%
2019-12-31 ₩22.70 Billion
≈ $15.38 Million
₩-4.38 Billion
≈ $-2.97 Million
-0.193x +32.29%
2018-12-31 ₩18.37 Billion
≈ $12.45 Million
₩-5.23 Billion
≈ $-3.55 Million
-0.285x +29.34%
2017-12-31 ₩20.42 Billion
≈ $13.84 Million
₩-8.24 Billion
≈ $-5.58 Million
-0.403x -46.84%
2016-12-31 ₩22.41 Billion
≈ $15.18 Million
₩-6.15 Billion
≈ $-4.17 Million
-0.275x +1.90%
2015-12-31 ₩23.86 Billion
≈ $16.17 Million
₩-6.68 Billion
≈ $-4.53 Million
-0.280x -229.13%
2014-12-31 ₩29.52 Billion
≈ $20.00 Million
₩-2.51 Billion
≈ $-1.70 Million
-0.085x --

About NSN Co. Ltd

KQ:031860 Korea Diagnostics & Research
Market Cap
$12.68 Million
₩18.71 Billion KRW
Market Cap Rank
#26457 Global
#1942 in Korea
Share Price
₩693.00
Change (1 day)
+17.26%
52-Week Range
₩265.00 - ₩1221.00
All Time High
₩146500.00
About

DHX Company Co., Ltd. engages in biomedical and distribution businesses in South Korea. The company offers Microbiome to treat intractable skin diseases; REJURUB; and AI digital brain diagnostic device. It also purchases and distributes IT components, including graphics cards, DRAM, CPUs, high-capacity storage, and multi-purpose displays; import and distribution of cosmetics; f and b distribution… Read more